Cleveland Clinic   

Questions discussed in this category


Do you incorporate PEG-asparaginase or brentuximab vedotin (for CD30-expressing malignant cells) into anthracycline-based induction regimens? Do you c...


Papers discussed in this category


Ann Oncol, 2007 Nov 15

Zhonghua Bing Li Xue Za Zhi,

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009-03-10

The New England journal of medicine, 2015-11-05

Haematologica, 2018 May 24

Blood,

Leukemia, 2011 Jul 01

Haematologica, 2019 Sep 19

Blood, 2017 Aug 17

Blood, 2015 May 28

British journal of haematology, 2017-11

J Clin Oncol, 2016 Feb 29

Lancet Haematol, 2016 Dec 05

Lancet Oncol, 2022 Jan 21

N Engl J Med,

N Engl J Med, 2022 Dec 11

J Clin Oncol, 2022 Dec 22

Blood Adv, 2022 May 10

Blood, 2022 Dec 15

J Clin Oncol, 2021 Jun 25

Annals of oncology : official journal of the European Society for Medical Oncology, 1993-11

Lancet (London, England), 2019-01-19

Blood, 2022 Mar 03

Lancet,

N Engl J Med, 2021 Dec 11